US Patent

US8561859 — Dispensing device

Formulation · Assigned to Aptar Radolfzell GmbH · Expires 2032-04-16 · 6y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a dispensing device for dispensing liquid media, such as a medication like Sandimmune, with a flow brake feature.

USPTO Abstract

A dispensing device for dispensing liquid media having a housing, an outlet opening for the medium, a medium reservoir for storage of the medium and a conveying device for transporting the medium from the medium reservoir to the outlet opening, wherein a flow brake is provided in a medium duct between the conveying device and the outlet opening. The flow brake has a first flow brake component which can be arranged and fixed relative to the housing or to a second flow brake component during assembly in several differing relative positions, wherein differing flow resistances of the flow brake are achieved depending on the selected relative positions.

Drugs covered by this patent

Patent Metadata

Patent number
US8561859
Jurisdiction
US
Classification
Formulation
Expires
2032-04-16
Drug substance claim
No
Drug product claim
Yes
Assignee
Aptar Radolfzell GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.